TY  - GEN
AU  - Barba,Pere
AU  - Morgades,Mireia
AU  - Montesinos,Pau
AU  - Gil,Cristina
AU  - Fox,María-Laura
AU  - Ciudad,Juana
AU  - Moreno,María-José
AU  - González-Campos,José
AU  - Genescà,Eulàlia
AU  - Martínez-Carballeira,Daniel
AU  - Martino,Rodrigo
AU  - Vives,Susana
AU  - Guardia,Ramon
AU  - Mercadal,Santiago
AU  - Artola,María-Teresa
AU  - Cladera,Antonia
AU  - Tormo,Mar
AU  - Esteve,Jordi
AU  - Bergua,Juan
AU  - Vall-Llovera,Ferran
AU  - Ribera,Jordi
AU  - Martínez-Sanchez,Pilar
AU  - Amigo,María-Luz
AU  - Bermúdez,Arantxa
AU  - Calbacho,María
AU  - Hernández-Rivas,Jesús-Maria
AU  - Feliu,Evaristo
AU  - Orfao,Alberto
AU  - Ribera,Josep-María
TI  - Increased survival due to lower toxicity for high-risk T-cell acute lymphoblastic leukemia patients in two consecutive pediatric-inspired PETHEMA trials
SN  - 1600-0609
PY  - 2019///0520
KW  - Adolescent
KW  - Adult
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Combined Modality Therapy
KW  - Consolidation Chemotherapy
KW  - Female
KW  - Genetic Testing
KW  - Hematopoietic Stem Cell Transplantation
KW  - Humans
KW  - Immunophenotyping
KW  - Induction Chemotherapy
KW  - Male
KW  - Middle Aged
KW  - Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
KW  - diagnosis
KW  - Recurrence
KW  - Risk Factors
KW  - Transplantation, Homologous
KW  - Treatment Outcome
KW  - Young Adult
N1  - Publication Type: Clinical Trial; Journal Article
UR  - https://doi.org/10.1111/ejh.13178
ER  -